Boston Scientific Corp's Fiscal Year is From January To December - All Figures are in USD, Millions.
The item "Interest-Expense" stands at 363.00 Million United States Dollars for the trailing twelve months (TTM) period ending 06/30/2026.
Boston Scientific Corp's second quarter result of 96.00 Million USD for the item "Interest Expense" represents an increase of 6.67 percent compared to it's first quarter result.
Also, Boston Scientific Corp's second quarter result of 96.00 Million USD for the item "Interest Expense" represents an increase of 6.67 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Boston Scientific Corp's second quarter result of 363.00 Million USD for the item "Interest Expense" represents an increase of 1.68 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -9.02 percent compared to the value the year prior.
The 1 year change in percent is -9.02.
The 3 year change in percent is 35.96.
The 5 year change in percent is -0.2747.
The 10 year change in percent is 54.47.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Abbott Laboratories - Interest Expense | 217,696,616,448.00 |
![]() | Intuitive Surgical Inc - Interest Expense | 206,245,888,000.00 |
![]() | EssilorLuxottica S. A. - Interest Expense | 172,241,486,586.05 |
![]() | Danaher Corporation - Interest Expense | 162,006,663,168.00 |
![]() | Stryker Corporation - Interest Expense | 139,209,850,880.00 |